SciELO - Brasil - Treatment of chronic hepatitis C in treatment-naïve patients Treatment of chronic hepatitis C in treatment-naïve patients
Ropeginterferon alfa-2b every 2 weeks as a novel pegylated interferon for patients with chronic hepatitis B | SpringerLink
Interferon: Long-Term Side Effects
Frontiers | Type III Interferons in Hepatitis C Virus Infection
Frontiers | Maternal and Fetal Outcomes After Interferon Exposure During Pregnancy: A Systematic Review With Meta-Analysis
SIDE EFFECTS OF TREATMENT WITH INTERFERON ALFA AND RIBAVIRIN. | Download Table
Contraindications for treatment with pegylated interferon and ribavirin | Download Table
Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection | NEJM
:max_bytes(150000):strip_icc()/pegasys-568530305f9b586a9e15ec79.jpg "Pegylated Interferon: Definition, Types, Uses")
Pegylated Interferon: Definition, Types, Uses
Final Appraisal Determination - Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatit
Short versus standard treatment with Pegylated interferon alfa-2a plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the CLEO trial. – topic of research paper in Clinical medicine. Download
kjhep-17-183-g001.jpg
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial - The Lancet
JCM | Free Full-Text | Outcomes and Follow-Up after Hepatitis C Eradication with Direct-Acting Antivirals
Full article: Pegylated interferon 2a and 2b in combination with ribavirin for the treatment of chronic hepatitis C in HIV infected patients
Adverse events of pegylated interferon-α (or interferon-α) and ribavirin | Download Table
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial - The Lancet
Peginterferon and Ribavirin for Chronic Hepatitis C | NEJM
Cureus | Sofosbuvir/Velpatasvir - A Promising Treatment for Chronic Hepatitis C Virus Infection | Article
Psychiatric side effects of pegylated interferon‑α and ribavirin therapy in Iranian patients with chronic hepatitis C: A meta‑analysis
PDF) Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan | Kow-tong Chen - Academia.edu
Peginterferon and Ribavirin for Chronic Hepatitis C | NEJM
Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology
Full article: Dyspnoea in patients with chronic hepatitis C treated with pegylated interferon and ribavirin
